413 related articles for article (PubMed ID: 22288676)
21. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
Liao X; Wang Y; Pan Y; Wang C; Zhao X; Wang DZ; Wang C; Liu L; Wang Y;
Stroke; 2014 Aug; 45(8):2354-8. PubMed ID: 25013020
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of IV-TPA for ischaemic stroke in clinical practice--a Bayesian analysis.
O'Rourke KE; Walsh CD; Kelly PJ
Cerebrovasc Dis; 2009; 28(6):572-81. PubMed ID: 19844097
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound enhanced thrombolysis in acute arterial ischemia.
Tsivgoulis G; Culp WC; Alexandrov AV
Ultrasonics; 2008 Aug; 48(4):303-11. PubMed ID: 18511094
[TBL] [Abstract][Full Text] [Related]
24. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.
Shahjouei S; Tsivgoulis G; Bavarsad Shahripour R; Jones GM; Alexandrov AV; Zand R
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2685-93. PubMed ID: 26542821
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
[TBL] [Abstract][Full Text] [Related]
26. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
[TBL] [Abstract][Full Text] [Related]
27. Thrombolysis in acute childhood stroke: design and challenges of the thrombolysis in pediatric stroke clinical trial.
Amlie-Lefond C; Chan AK; Kirton A; deVeber G; Hovinga CA; Ichord R; Stephens D; Zaidat OO;
Neuroepidemiology; 2009; 32(4):279-86. PubMed ID: 19223687
[TBL] [Abstract][Full Text] [Related]
28. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
29. Predictors of good clinical outcome in acute stroke patients treated with intravenous thrombolysis.
Saňák D; Herzig R; Zapletalová J; Horák D; Král M; Skoloudík D; Bártková A; Veverka T; Heřman M; Kaňovský P
Acta Neurol Scand; 2011 May; 123(5):339-44. PubMed ID: 20597864
[TBL] [Abstract][Full Text] [Related]
30. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.
Ciccone A; Valvassori L; Nichelatti M;
Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814
[TBL] [Abstract][Full Text] [Related]
31. Update on intravenous recombinant tissue plasminogen activator for acute ischemic stroke.
Fugate JE; Rabinstein AA
Mayo Clin Proc; 2014 Jul; 89(7):960-72. PubMed ID: 24775222
[TBL] [Abstract][Full Text] [Related]
32. [Prospects of thrombolytic therapy for acute ischemic stroke].
Nakashima T; Minematsu K
Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
[TBL] [Abstract][Full Text] [Related]
33. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
[TBL] [Abstract][Full Text] [Related]
34. Intravenous thrombolytic therapy for acute ischemic stroke.
Wechsler LR
N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326
[No Abstract] [Full Text] [Related]
35. Thromobolysis for acute ischemic stroke: is intra-arterial better than intravenous? A treatment effects model.
Powers WJ
J Stroke Cerebrovasc Dis; 2012 Jul; 21(5):401-3. PubMed ID: 22464277
[TBL] [Abstract][Full Text] [Related]
36. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy?
Uchino K; Massaro L; Hammer MD
Cerebrovasc Dis; 2010; 29(1):57-61. PubMed ID: 19893313
[TBL] [Abstract][Full Text] [Related]
37. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
Sobesky J; Frackowiak M; Zaro Weber O; Hahn M; Möller-Hartmann W; Rudolf J; Neveling M; Grond M; Schmulling S; Jacobs A; Heiss WD
Cerebrovasc Dis; 2007; 24(1):56-65. PubMed ID: 17519545
[TBL] [Abstract][Full Text] [Related]
38. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
[TBL] [Abstract][Full Text] [Related]
39. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
Mehta RH; Cox M; Smith EE; Xian Y; Bhatt DL; Fonarow GC; Peterson ED;
Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958
[TBL] [Abstract][Full Text] [Related]
40. Current acute stroke trials and their potential impact on the therapeutic time window.
Schellinger PD; Köhrmann M
Expert Rev Neurother; 2012 Feb; 12(2):169-77. PubMed ID: 22288672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]